Celgene Reports Positive Psoriasis Results For Anti-Inflammatory Candidate
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm will outline a clinical and regulatory strategy for CC-10004 by late July, Celgene tells “The Pink Sheet” DAILY.